Pfizer Covid Pill
-
{
- All
- News
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms
South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.
-
Joe Biden Doubles US Purchase Of Pfizer Covid Pills As Cases Surge
President Joe Biden announced Tuesday a doubling of US government purchases of new Pfizer therapeutic pills designed to combat the worst effects of Covid-19.
-
South Korea Authorises Emergency Use Of Pfizer's Antiviral Covid Pill
South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety.
-
European Union Medical Body Approves Pfizer Covid Pill For Emergency Use
The European Union's drug regulator on Thursday approved Pfizer's Covid pill for emergency use by individual member states struggling with the new wave of the disease, pending formal approval across the bloc.
-
Pfizer Covid Pill Nearly 90% Effective, Works On Omicron, Shows Lab Data
Pfizer Inc on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast
-
Pfizer Announces Plan To Sell 10 Million Covid Pills To US For Over $5 Billion
Pfizer said Thursday it will sell 10 million COVID-19 treatment courses for COVID-19 to the US government for $5.3 billion, pending approval from regulators.
-
Dr Reddy's Open To Making Pfizer Covid Pill
Dr Reddy's Laboratories, one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said on Monday it was open to making a similar pill from Pfizer, thought to be even more effective.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms
South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.
-
Joe Biden Doubles US Purchase Of Pfizer Covid Pills As Cases Surge
President Joe Biden announced Tuesday a doubling of US government purchases of new Pfizer therapeutic pills designed to combat the worst effects of Covid-19.
-
South Korea Authorises Emergency Use Of Pfizer's Antiviral Covid Pill
South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety.
-
European Union Medical Body Approves Pfizer Covid Pill For Emergency Use
The European Union's drug regulator on Thursday approved Pfizer's Covid pill for emergency use by individual member states struggling with the new wave of the disease, pending formal approval across the bloc.
-
Pfizer Covid Pill Nearly 90% Effective, Works On Omicron, Shows Lab Data
Pfizer Inc on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast
-
Pfizer Announces Plan To Sell 10 Million Covid Pills To US For Over $5 Billion
Pfizer said Thursday it will sell 10 million COVID-19 treatment courses for COVID-19 to the US government for $5.3 billion, pending approval from regulators.
-
Dr Reddy's Open To Making Pfizer Covid Pill
Dr Reddy's Laboratories, one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said on Monday it was open to making a similar pill from Pfizer, thought to be even more effective.
